Femasys Inc. (FEMY)
USD 1.12
(-2.61%)
USD 1.12
(-2.61%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 667.11 Thousand USD | 52.76% |
| 2022 | 436.72 Thousand USD | 109.69% |
| 2021 | 208.27 Thousand USD | 58.53% |
| 2020 | 131.37 Thousand USD | -23.84% |
| 2019 | 172.49 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.31 Million USD | 35.45% |
| 2024 Q1 | 971.29 Thousand USD | 45.6% |
| 2023 FY | 667.11 Thousand USD | 52.76% |
| 2023 Q2 | 581.47 Thousand USD | 16.12% |
| 2023 Q1 | 500.74 Thousand USD | 14.66% |
| 2023 Q4 | 667.11 Thousand USD | 10.69% |
| 2023 Q3 | 602.66 Thousand USD | 3.64% |
| 2022 Q4 | 436.72 Thousand USD | 27.27% |
| 2022 Q2 | 244.18 Thousand USD | 9.49% |
| 2022 Q1 | 223 Thousand USD | 7.08% |
| 2022 FY | 436.72 Thousand USD | 109.69% |
| 2022 Q3 | 343.13 Thousand USD | 40.53% |
| 2021 Q1 | 144.05 Thousand USD | 9.65% |
| 2021 FY | 208.27 Thousand USD | 58.53% |
| 2021 Q4 | 208.27 Thousand USD | 38.54% |
| 2021 Q3 | 150.33 Thousand USD | 2.35% |
| 2021 Q2 | 146.87 Thousand USD | 1.96% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 131.37 Thousand USD | 0.0% |
| 2020 FY | 131.37 Thousand USD | -23.84% |
| 2019 FY | 172.49 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 96.268% |
| AngioDynamics, Inc. | 60.61 Million USD | 98.899% |
| AtriCure, Inc. | 67.89 Million USD | 99.017% |
| Avinger, Inc. | 5.29 Million USD | 87.408% |
| Azenta, Inc. | 128.19 Million USD | 99.48% |
| BioLife Solutions, Inc. | 43.45 Million USD | 98.465% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.909% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 86.79% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 97.301% |
| Hologic, Inc. | 679.8 Million USD | 99.902% |
| ICU Medical, Inc. | 709.36 Million USD | 99.906% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.945% |
| KORU Medical Systems, Inc. | 3.48 Million USD | 80.837% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 98.725% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | 22.135% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | 22.135% |
| Masimo Corporation | 545 Million USD | 99.878% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 58.749% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 99.78% |
| Nephros, Inc. | 2.47 Million USD | 72.991% |
| NovoCure Limited | 38.15 Million USD | 98.251% |
| NEXGEL, Inc. | 1.31 Million USD | 49.422% |
| NEXGEL, Inc. | 1.31 Million USD | 49.422% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 95.085% |
| OraSure Technologies, Inc. | 47.61 Million USD | 98.599% |
| Pro-Dex, Inc. | 15.26 Million USD | 95.631% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -34.942% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | 76.74% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.885% |
| Repligen Corporation | 202.32 Million USD | 99.67% |
| Sanara MedTech Inc. | 4.71 Million USD | 85.859% |
| STAAR Surgical Company | 35.13 Million USD | 98.101% |
| Sharps Technology, Inc. | 1.7 Million USD | 60.968% |
| Utah Medical Products, Inc. | 9.58 Million USD | 93.038% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.893% |
| Jin Medical International Ltd. | 5.05 Million USD | 86.798% |